These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20218620)

  • 41. Structure-based screening, ADMET profiling, and molecular dynamic studies on mGlu2 receptor for identification of newer antiepileptic agents.
    Malik R; Mehta P; Srivastava S; Choudhary BS; Sharma M
    J Biomol Struct Dyn; 2017 Dec; 35(16):3433-3448. PubMed ID: 27822979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ancestral reconstruction of the ligand-binding pocket of Family C G protein-coupled receptors.
    Kuang D; Yao Y; Maclean D; Wang M; Hampson DR; Chang BS
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14050-5. PubMed ID: 16966606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current trends in ligand-based virtual screening: molecular representations, data mining methods, new application areas, and performance evaluation.
    Geppert H; Vogt M; Bajorath J
    J Chem Inf Model; 2010 Feb; 50(2):205-16. PubMed ID: 20088575
    [No Abstract]   [Full Text] [Related]  

  • 44. Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening.
    Cai H; Yan G; Zhang X; Gorbenko O; Wang H; Zhu W
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3675-9. PubMed ID: 20471252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug discovery: phosphinolactone, in vivo bioisostere of the lactol group.
    Volle JN; Filippini D; Krawczy B; Kaloyanov N; Van der Lee A; Maurice T; Pirat JL; Virieux D
    Org Biomol Chem; 2010 Mar; 8(6):1438-44. PubMed ID: 20204219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determination of L-AP4-bound human mGlu8 receptor amino terminal domain structure and the molecular basis for L-AP4's group III mGlu receptor functional potency and selectivity.
    Schkeryantz JM; Chen Q; Ho JD; Atwell S; Zhang A; Vargas MC; Wang J; Monn JA; Hao J
    Bioorg Med Chem Lett; 2018 Feb; 28(4):612-617. PubMed ID: 29402739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Α-amino-β-fluorocyclopropanecarboxylic acids as a new tool for drug development: synthesis of glutamic acid analogs and agonist activity towards metabotropic glutamate receptor 4.
    Lemonnier G; Lion C; Quirion JC; Pin JP; Goudet C; Jubault P
    Bioorg Med Chem; 2012 Aug; 20(15):4716-26. PubMed ID: 22750138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New perspectives for the development of selective metabotropic glutamate receptor ligands.
    Pin JP; De Colle C; Bessis AS; Acher F
    Eur J Pharmacol; 1999 Jun; 375(1-3):277-94. PubMed ID: 10443583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure-based design and synthesis of novel thrombin inhibitors based on phosphinic peptide mimetics.
    Li M; Lin Z; Johnson ME
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1957-62. PubMed ID: 10450962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and biological activities of conformationally restricted cyclopentenyl-glutamate analogues.
    Ung AT; Schafer K; Lindsay KB; Pyne SG; Amornraksa K; Wouters R; Van der Linden I; Biesmans I; Lesage AS; Skelton BW; White AH
    J Org Chem; 2002 Jan; 67(1):227-33. PubMed ID: 11777464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrated synthetic, pharmacological, and computational investigation of cis-2-(3,5-dichlorophenylcarbamoyl)cyclohexanecarboxylic acid enantiomers as positive allosteric modulators of metabotropic glutamate receptor subtype 4.
    Christov C; González-Bulnes P; Malhaire F; Karabencheva T; Goudet C; Pin JP; Llebaria A; Giraldo J
    ChemMedChem; 2011 Jan; 6(1):131-40. PubMed ID: 21132834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Receptor cloning and heterologous expression--towards a new tool for drug discovery.
    Luyten WH; Leysen JE
    Trends Biotechnol; 1993 Jun; 11(6):247-54. PubMed ID: 7764062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis of novel N-phosphonoalkyl dipeptide inhibitors of human collagenase.
    Bird J; De Mello RC; Harper GP; Hunter DJ; Karran EH; Markwell RE; Miles-Williams AJ; Rahman SS; Ward RW
    J Med Chem; 1994 Jan; 37(1):158-69. PubMed ID: 8289190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Making virtual screening a reality.
    Koh JT
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):6902-3. PubMed ID: 12782796
    [No Abstract]   [Full Text] [Related]  

  • 55. Design and pharmacological activity of phosphinic acid based NAALADase inhibitors.
    Jackson PF; Tays KL; Maclin KM; Ko YS; Li W; Vitharana D; Tsukamoto T; Stoermer D; Lu XC; Wozniak K; Slusher BS
    J Med Chem; 2001 Nov; 44(24):4170-5. PubMed ID: 11708918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular modeling of the mGluR1 metabotropic glutamate receptor transmembrane domain and construction of the model of its dimer.
    Belenikin MS; Costantino G; Palyulin VA; Pellicciari R; Zefirov NS
    Dokl Biochem Biophys; 2003; 393():341-5. PubMed ID: 14870616
    [No Abstract]   [Full Text] [Related]  

  • 57. Fungicidal activity of phosphinic analogues of amino acids involved in methionine metabolism.
    Zhukov YN; Vavilova NA; Osipova TI; Voinova TM; Khurs EN; Dzhavakhia VG; Khomutov RM
    Dokl Biochem Biophys; 2004; 397():210-2. PubMed ID: 15523827
    [No Abstract]   [Full Text] [Related]  

  • 58. A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential.
    Goudet C; Vilar B; Courtiol T; Deltheil T; Bessiron T; Brabet I; Oueslati N; Rigault D; Bertrand HO; McLean H; Daniel H; Amalric M; Acher F; Pin JP
    FASEB J; 2012 Apr; 26(4):1682-93. PubMed ID: 22223752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiviral activities of natural compounds and ionic liquids to inhibit the Mpro of SARS-CoV-2: a computational approach.
    Palanisamy K; Rubavathy SME; Prakash M; Thilagavathi R; Hosseini-Zare MS; Selvam C
    RSC Adv; 2022 Jan; 12(6):3687-3695. PubMed ID: 35425367
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.